Drug
Secutrelvir
Secutrelvir: highest development phase Phase 3, developed by Shionogi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Secutrelvir NCT07743580 | Phase 3 | SARS-CoV-2 |
| Secutrelvir NCT07746544 | Phase 3 | COVID-19 |
Latest
No recent events.
Follow Secutrelvir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.